Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

NCT00975533 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DEVICE: Tantalus
DRUG: Insulin

Sponsor

Chinese University of Hong Kong

Collaborators

[object Object]